U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.1540G>T (p.Gly514Cys) AND Cardiac conduction defect, nonprogressive

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Feb 22, 2001
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000009984.3

Allele description [Variation Report for NM_000335.5(SCN5A):c.1540G>T (p.Gly514Cys)]

NM_000335.5(SCN5A):c.1540G>T (p.Gly514Cys)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.1540G>T (p.Gly514Cys)
HGVS:
  • NC_000003.12:g.38604062C>A
  • NG_008934.1:g.50611G>T
  • NM_000335.5:c.1540G>TMANE SELECT
  • NM_001099404.2:c.1540G>T
  • NM_001099405.2:c.1540G>T
  • NM_001160160.2:c.1540G>T
  • NM_001160161.2:c.1540G>T
  • NM_001354701.2:c.1540G>T
  • NM_198056.3:c.1540G>T
  • NP_000326.2:p.Gly514Cys
  • NP_001092874.1:p.Gly514Cys
  • NP_001092875.1:p.Gly514Cys
  • NP_001153632.1:p.Gly514Cys
  • NP_001153633.1:p.Gly514Cys
  • NP_001341630.1:p.Gly514Cys
  • NP_932173.1:p.Gly514Cys
  • NP_932173.1:p.Gly514Cys
  • LRG_289t1:c.1540G>T
  • LRG_289:g.50611G>T
  • LRG_289p1:p.Gly514Cys
  • NC_000003.11:g.38645553C>A
  • NM_198056.2:c.1540G>T
  • Q14524:p.Gly514Cys
Protein change:
G514C; GLY514CYS
Links:
UniProtKB: Q14524#VAR_017673; OMIM: 600163.0016; dbSNP: rs137854606
NCBI 1000 Genomes Browser:
rs137854606
Molecular consequence:
  • NM_000335.5:c.1540G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.1540G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.1540G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160160.2:c.1540G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160161.2:c.1540G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.1540G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.1540G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiac conduction defect, nonprogressive
Identifiers:
MedGen: C1861984

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000030205OMIM
no assertion criteria provided
Pathogenic
(Feb 22, 2001)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

A sodium-channel mutation causes isolated cardiac conduction disease.

Tan HL, Bink-Boelkens MT, Bezzina CR, Viswanathan PC, Beaufort-Krol GC, van Tintelen PJ, van den Berg MP, Wilde AA, Balser JR.

Nature. 2001 Feb 22;409(6823):1043-7.

PubMed [citation]
PMID:
11234013

Details of each submission

From OMIM, SCV000030205.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Tan et al. (2001) studied a family who came to medical attention when the proband, a 3-year-old girl, experienced episodes of fainting during a febrile illness. Her 12-lead ECG showed characteristics of slow conduction throughout the atria and ventricles, including broad P waves, PR interval prolongation, and a wide QRS complex (see 113900). Continuous monitoring revealed episodes of severe bradycardia (25 beats/minute). During these slow periods the cardiac rhythm was maintained by infrequent atrioventricular nodal 'escape' impulses. Conduction disturbance persisted after the febrile illness, but there was no evidence of structural heart disease or systemic diseases associated with conduction defects in children. Therapeutic intervention with a dual-chamber pacemaker was initially limited by inability to pace the atrium (maximal stimulus: 10 V, 1 ms); however, this difficulty resolved with 1 week of empiric steroid treatment. During the 4 years following diagnosis, the patient continuously required dual-chamber pacing. The proband's 6-year-old sister was similarly affected and required pacemaker implantation, with episodes of noncapture that reproducibly resolved with corticosteroid therapy. Three other family members with no structural heart disease had ECG evidence of conduction slowing (prolonged PR and QRS intervals), but did not experience bradycardia or require pacemaker implantation. All affected family members had a G-to-T transversion in the first nucleotide of codon 514 in exon 12 of the SCN5A gene resulting in the replacement of glycine by cysteine (G514C). Biophysical characterization of the mutant channel showed that there were abnormalities in voltage-dependent gating behavior that could be partially corrected by dexamethasone, consistent with the salutary effects of glucocorticoids on the clinical phenotype. Computational analysis predicts that the gating defects of G514C selectively slow myocardial conduction, but do not provoke the rapid cardiac arrhythmias associated previously with SCN5A mutations.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2022